Ashleigh Palmer, President and CEO at Provention Bio, Inc. (PRVB), bought 37,500 shares at $4.00 ($150K) on 2018-07-19, disclosed to the SEC on 2018-07-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| PRVB | BUY | 2021-12-01 | $25K | — | Filing → |
| PRVB | BUY | 2020-08-18 | $6K | — | Filing → |
| PRVB | BUY | 2020-08-17 | $36K | — | Filing → |